Race-Based Differences in Lipoprotein(a)-Associated Risk of Carotid Atherosclerosis: The Multi-Ethnic Study of Atherosclerosis

Objective— Lp(a) [lipoprotein(a)] is a well-described risk factor for atherosclerosis, but Lp(a)-associated risk may vary by race/ethnicity. We aimed to determine whether race/ethnicity modifies Lp(a)-related risk of carotid atherosclerotic plaque outcomes among black, white, Chinese, and Hispanic individuals. Approach and Results— Carotid plaque presence and score were assessed by ultrasonography at baseline (n=5155) and following a median 9.4 year period (n=3380) in MESA (Multi-Ethnic Study of Atherosclerosis) participants. Lp(a) concentrations were measured by immunoassay and examined as a continuous and categorical variable using clinically-based cutoffs, 30 and 50 mg/dL. Lp(a) was related to greater risk of prevalent carotid plaque at baseline in whites alone (all P<0.001): per log unit (relative risk, 1.05); Lp(a)≥30 mg/dL (relative risk, 1.16); and Lp(a)≥50 mg/dL (relative risk, 1.20). Lp(a) levels over 50 mg/dL were associated with a higher plaque score at baseline in whites (all P<0.001) and Hispanics (P=0.04). In prospective analyses, whites with Lp(a) ≥50 mg/dL were found to have greater risk of plaque progression (relative risk, 1.12; P=0.03) and higher plaque scores (all P<0.001) over the 9.4-year follow-up. Race-based differences between whites and black participants were significant for cross-sectional associations and for carotid plaque score following the 9.4 year study period. Conclusions— Race was found to be a modifying variable in Lp(a)-related risk of carotid plaque, and Lp(a) levels may have greater influence on plaque burden in whites than in black individuals. Borderline results in Hispanics suggest that elevated Lp(a) may increase the risk of carotid plaque, but follow-up studies are needed.

[1]  S. Grundy,et al.  2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2019, Journal of the American College of Cardiology.

[2]  W. Guan,et al.  Lp(a) [Lipoprotein(a)]-Related Risk of Heart Failure Is Evident in Whites but Not in Other Racial/Ethnic Groups: The Multi-Ethnic Study of Atherosclerosis , 2018, Arteriosclerosis, thrombosis, and vascular biology.

[3]  R. Planken,et al.  Elevated lipoprotein(a) levels are associated with coronary artery calcium scores in asymptomatic individuals with a family history of premature atherosclerotic cardiovascular disease. , 2018, Journal of clinical lipidology.

[4]  Yuan-Lin Guo,et al.  Lipoprotein(a) level associates with coronary artery disease rather than carotid lesions in patients with familial hypercholesterolemia , 2018, Journal of clinical laboratory analysis.

[5]  C. Yuan,et al.  Lp(a) (Lipoprotein(a)) Levels Predict Progression of Carotid Atherosclerosis in Subjects With Atherosclerotic Cardiovascular Disease on Intensive Lipid Therapy: An Analysis of the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides Impact on Global Health Ou , 2018, Arteriosclerosis, thrombosis, and vascular biology.

[6]  M. Woodward,et al.  Twenty‐Year Predictors of Peripheral Arterial Disease Compared With Coronary Heart Disease in the Scottish Heart Health Extended Cohort (SHHEC) , 2017, Journal of the American Heart Association.

[7]  C. Gieger,et al.  A genome-wide association meta-analysis on lipoprotein (a) concentrations adjusted for apolipoprotein (a) isoforms[S] , 2017, Journal of Lipid Research.

[8]  César Martín,et al.  PCSK9 and lipoprotein (a) levels are two predictors of coronary artery calcification in asymptomatic patients with familial hypercholesterolemia. , 2016, Atherosclerosis.

[9]  B. Nordestgaard,et al.  Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology , 2016, Journal of Lipid Research.

[10]  A. Hoes,et al.  2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. , 2016, European heart journal.

[11]  E. Fishman,et al.  Relation of Plasma Lipoprotein(a) to Subclinical Coronary Plaque Volumes, Three-Vessel and Left Main Coronary Disease, and Severe Coronary Stenoses in Apparently Healthy African-Americans With a Family History of Early-Onset Coronary Artery Disease. , 2016, The American journal of cardiology.

[12]  W. Guan,et al.  Lipoprotein(a) Levels Are Associated With Subclinical Calcific Aortic Valve Disease in White and Black Individuals: The Multi-Ethnic Study of Atherosclerosis , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[13]  A. Zwinderman,et al.  Heterogeneous impact of classic atherosclerotic risk factors on different arterial territories: the EPIC-Norfolk prospective population study. , 2016, European heart journal.

[14]  M. Criqui,et al.  Sex and ethnic differences in the associations between lipoprotein(a) and peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis. , 2016, Journal of vascular surgery.

[15]  J. Borén,et al.  Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment , 2015, European heart journal.

[16]  W. Guan,et al.  Race Is a Key Variable in Assigning Lipoprotein(a) Cutoff Values for Coronary Heart Disease Risk Assessment: The Multi-Ethnic Study of Atherosclerosis , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[17]  David Reich,et al.  The Genetic Ancestry of African Americans, Latinos, and European Americans across the United States , 2015, American journal of human genetics.

[18]  Lianne Sheppard,et al.  Predictors of Carotid Thickness and Plaque Progression During a Decade: The Multi-Ethnic Study of Atherosclerosis , 2014, Stroke.

[19]  Mantian Chen,et al.  Serum Lipoprotein(a) Positively Correlates with Coronary Artery Calcification in Low-Risk Chinese Han Patients: A Study from a Single Center , 2013, PloS one.

[20]  Kathleen F. Kerr,et al.  Genetic associations with valvular calcification and aortic stenosis. , 2013, The New England journal of medicine.

[21]  C. Becker,et al.  Lipoprotein (a) is independently correlated with coronary artery calcification. , 2013, European journal of internal medicine.

[22]  M. Reilly,et al.  Lipoprotein(a) is strongly associated with coronary artery calcification in type-2 diabetic women. , 2011, International journal of cardiology.

[23]  M. Taskinen,et al.  [ESC/EAS Guidelines for the management of dyslipidaemias]. , 2011, Revista espanola de cardiologia.

[24]  Zahi A Fayad,et al.  2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2010, Journal of the American College of Cardiology.

[25]  J. Borén,et al.  Lipoprotein(a) as a cardiovascular risk factor: current status , 2010, European heart journal.

[26]  A. Khera,et al.  Relationship of Oxidized Phospholipids on Apolipoprotein B-100 Particles to Race/Ethnicity, Apolipoprotein(a) Isoform Size, and Cardiovascular Risk Factors: Results From the Dallas Heart Study , 2009, Circulation.

[27]  M. Koschinsky,et al.  Apolipoprotein(a), through Its Strong Lysine-binding Site in KIV10, Mediates Increased Endothelial Cell Contraction and Permeability via a Rho/Rho Kinase/MYPT1-dependent Pathway* , 2008, Journal of Biological Chemistry.

[28]  R. Kronmal,et al.  Cholesteryl ester transfer protein genetic polymorphisms, HDL cholesterol, and subclinical cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis. , 2008, Atherosclerosis.

[29]  M. Koschinsky,et al.  Lipoprotein(a) Is Associated Differentially With Carotid Stenosis, Occlusion, and Total Plaque Area , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[30]  Jonathan C. Cohen,et al.  Lipoprotein(a) and Apolipoprotein(a) Isoforms: No Association With Coronary Artery Calcification in The Dallas Heart Study , 2005, Circulation.

[31]  Manfred Dietel,et al.  Morphological detection and quantification of lipoprotein(a) deposition in atheromatous lesions of human aorta and coronary arteries , 2005, Virchows Archiv A.

[32]  E. Boerwinkle,et al.  Lack of association between lipoprotein(a) and coronary artery calcification in the Genetic Epidemiology Network of Arteriopathy (GENOA) study. , 2004, Mayo Clinic proceedings.

[33]  L. Bielak,et al.  Sex-specific associations of lipoprotein(a) with presence and quantity of coronary artery calcification in an asymptomatic population. , 2004, Medical science monitor : international medical journal of experimental and clinical research.

[34]  A. Scanu.  Lp(a) lipoprotein--coping with heterogeneity. , 2003, The New England journal of medicine.

[35]  T. Iwamoto,et al.  Clinical significance of lipoprotein(a) in carotid plaque types and ischemic stroke in the elderly , 2003 .

[36]  R. Kronmal,et al.  Multi-Ethnic Study of Atherosclerosis: objectives and design. , 2002, American journal of epidemiology.

[37]  M. Nishino,et al.  Lack of association of lipoprotein(a) levels with coronary calcium deposits in asymptomatic postmenopausal women. , 2000, Journal of the American College of Cardiology.

[38]  E. Rubin,et al.  Lipoprotein(a) vascular accumulation in mice. In vivo analysis of the role of lysine binding sites using recombinant adenovirus. , 1997, The Journal of clinical investigation.

[39]  E. Rubin,et al.  Modification of apolipoprotein(a) lysine binding site reduces atherosclerosis in transgenic mice. , 1997, The Journal of clinical investigation.

[40]  E. Wijsman,et al.  Differences in Lp[a] concentrations and apo[a] polymorphs between black and white Americans. , 1996, Journal of lipid research.

[41]  G. Heiss,et al.  Race and gender differences in the association of Lp(a) with carotid artery wall thickness. The Atherosclerosis Risk in Communities (ARIC) Study. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[42]  S. Kiechl,et al.  Lipoprotein(a) and asymptomatic carotid artery disease. Evidence of a prominent role in the evolution of advanced carotid plaques: the Bruneck Study. , 1995, Stroke.

[43]  E. Boerwinkle,et al.  No association between plasma lipoprotein(a) concentrations and the presence or absence of coronary atherosclerosis in African-Americans. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[44]  U. Beisiegel,et al.  Extraction of lipoprotein(a), apo B, and apo E from fresh human arterial wall and atherosclerotic plaques. , 1995, Atherosclerosis.

[45]  Qi Chen,et al.  Immunostaining of human autopsy aortas with antibodies to modified apolipoprotein B and apoprotein(a). , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[46]  A. Simon,et al.  Serum Lp(a) as a discriminant marker of early atherosclerotic plaque at three extracoronary sites in hypercholesterolemic men. The PCVMETRA Group. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[47]  H. Hoff,et al.  Quantification of apo[a] and apoB in human atherosclerotic lesions. , 1991, Journal of lipid research.

[48]  V. Armstrong,et al.  Heterogeneity of human lipoprotein Lp[a]: cytochemical and biochemical studies on the interaction of two Lp[a] species with the LDL receptor. , 1990, Journal of lipid research.

[49]  M. Dietel,et al.  Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients. , 1989, Arteriosclerosis.